In England alone, approximately 57,000 people are receiving treatment for secondary breast cancer.
Around 30% of women diagnosed with early breast cancer will develop secondary breast cancer, where the disease spreads to other parts of the body such as the bones, lungs, liver, or brain. While secondary breast cancer can be treated, it currently cannot be cured.
Secondary cancers involving the brain are becoming increasingly common, posing significant challenges for treatment. Often, patients only become aware of the disease when they experience symptoms like seizures, headaches, or limb weakness.
At Clatterbridge Cancer Charity, we are committed to supporting groundbreaking research to improve the detection and treatment of secondary breast cancer. Professor Palmieri and his team will use £150,000 of your generous donations to conduct focused research aimed at identifying brain secondaries before symptoms arise. Their work will also explore whether the earliest signs of the disease can be detected in spinal fluid and investigate the most effective treatment methods.
This research has the potential to significantly reduce the impact of secondary breast cancer on patients and their families, offering hope for better outcomes and improved quality of life. Your support is crucial in making this vital research possible.
Sign up for our newsletter
We’d love to keep you updated about how you make a difference to the lives of patients and their families at The Clatterbridge Cancer Centre and more ways you can support the 1 in 2 people with cancer across our region.
Your details are safe with us. More information about how we protect your personal data is set out in our privacy policy.
